<DOC>
	<DOCNO>NCT00382291</DOCNO>
	<brief_summary>This study measure occurrence certain side effect link antidepressant use evaluate effectiveness medication sertraline plus cognitive behavioral therapy treat people obsessive-compulsive disorder .</brief_summary>
	<brief_title>Effectiveness Sertraline Cognitive Behavioral Therapy Treating Pediatric Obsessive-Compulsive Disorder</brief_title>
	<detailed_description>Obsessive-compulsive disorder ( OCD ) anxiety disorder associate recur repetitive behavior persistent unwanted thought . People OCD often carry ritual-like behavior count , cleaning , wash hand order momentarily ease anxiety . A current treatment people OCD class antidepressant call selective serotonin reuptake inhibitor ( SSRIs ) . A recent re-analysis clinical trial child psychiatric condition find risk suicidal thought behavior SSRI-antidepressants considerably high placebo . The data also reveal antidepressant-associated suicidal behavior limit child depression , also affect child OCD anxiety disorder . Although process responsible increase suicidality unknown , may initiate set symptom collectively call SSRI induce activation syndrome , thought common , particularly child teen . However , lack knowledge syndrome , include role suicidal behavior prevent . This study evaluate new behavioral test measure certain side effect link antidepressant use . This study also evaluate effectiveness SSRI sertraline plus cognitive behavioral therapy ( CBT ) treat people OCD . Potential participant undergo initial screen visit include interview psychological symptom associate OCD possible family history OCD . Eligible participant undergo physical exam , blood draw , DNA sampling , pregnancy test applicable . Participants randomly assign receive either sertraline placebo daily 18 week . At weekly study visit , participant receive study drug , complete questionnaire symptom OCD , undergo vital sign measurement . At specified visit , participant also perform task ( Stop Signal Task ) computerize assessment device measure attention impulse control may blood drawn . For first 4 week participant wear wristwatch-like device ( actigraph ) monitor sleep pattern . During first three visit , participant receive supportive psychotherapy . At Visit 4 , participant begin receive 60-minute CBT session , continue final visit . The final visit include second physical exam , questionnaire , blood testing .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Antidepressive Agents , Second-Generation</mesh_term>
	<criteria>Principal diagnosis OCD least 6month duration , determine structured clinical interview ( schedule affective disorder schizophrenia schoolage child ) As long OCD principal diagnosis , comorbid depression , attention deficit hyperactivity disorder , tic disorder , another anxiety disorder allowable Diagnosis trichotillomania body dysmorphic disorder provide OCD symptom predominant present feature Meets clinical criterion Pediatric Autoimmune Neuropsychiatric Disorders Associated Streptococcal Infections ( PANDAS ) ( e.g. , abrupt onset dramatic fluctuation symptom ) Prior adequate trial sertraline Allergy sertraline History rheumatic fever serious autoimmune disorder Diagnosis bipolar disorder , autism , schizophrenia , mental retardation , chronic degenerative neurological disease Current anorexia nervosa symptom body image distortion ( symptoms anorexia secondary obsession [ e.g. , contamination ] permit ) Unable safely swallow study medication pill swallow education Unwillingness child 's parent commit accompany child multiple study visit responsible medication compliance Suicidal intent ( suicidal ideation automatic exclusion ; however , risk gauge carefully participant must contract safety ) Suicide attempt 12 month prior study entry Pregnancy Taking monoamine oxidase inhibitor ( MAOIs ) within 4 week study entry fluoxetine within 5 week study entry Taking psychotropic medication sedative hypnotic insomnia Substance abuse dependence within 6 month prior study entry</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>OCD</keyword>
	<keyword>Antidepressive Agents , Second-Generation</keyword>
	<keyword>Placebos</keyword>
	<keyword>Cognitive Behavior Therapy</keyword>
	<keyword>Child Psychiatry</keyword>
	<keyword>Activation Syndrome</keyword>
	<keyword>Psychometrics</keyword>
</DOC>